Pune, India -- (SBWIRE) -- 05/13/2020 -- Infinium Global Research has recently published a global report on "Needle Free Drug Delivery Devices Market (Technology - Jet Injectors, Inhaler Technology, Transdermal Patch Technology, Novel Needle-free Technologies, and Oral Drug Delivery System; Application - Vaccine Delivery, Pain Management, Insulin Delivery for Diabetes, Pediatric Injections, and Other Applications): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025." The global needle-free drug delivery devices market is projected to grow at a CAGR of 10.3% over the forecast period of 2019-2025.

"We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report Shall be Revised to 2020-2026. The Section on the Impact of COVID-19 on Needle Free Drug Delivery Devices Market is Included in the Report for Free."

For More Details Get FREE Sample Pages of this Premium Global Report@ https://www.infiniumglobalresearch.com/reports/sample-request/13252

Growing Number of Diabetes Patients

The growing number of diabetes patients, rise in occurrence of needle born disease are major drivers driving the growth of the global needle-free drug delivery devices market globally. Diseases like HIV AIDS, Dengue, and Hepatitis are the major factors for the growth of the global market. According to the World Health Organization, HIV has claimed more than 32 million lives so far.

Improvement in the Immune Response of Vaccines

Approximately, 770 000 people died from HIV-related causes across the globe in 2018. Reduction in healthcare expenses and improvement in the immune response of vaccines also boosts the growth of the needle-free drug delivery devices market.  However, changing regulatory requirements and lack of skilled professionals may hamper the growth of the market.

Moreover, rising pressure to reduce the rate of needle borne infectious diseases and new technological development by competitors creates an opportunity for the growth of the global needle-free drug delivery devices market in the next few years.

North America Holds the Maximum Share

Geographically, the global needle-free drug delivery devices market is segmented into North America, Europe, Asia Pacific and the rest of the world. North America holds the maximum share and it is expected to dominate the market over the forecast period. This is attributed to the growing occurrence of chronic diseases. The Asia Pacific is anticipated to grow at a faster rate over the forecast period.

This is accredited to the growth in the geriatric population, increasing the incidence of diabetes in developing countries such as India and China. According to the International Diabetes Federation, around 11.4 billion individuals are suffering from diabetes in China and 7.2 billion people are suffering from diabetes in India.

Get this Section as a Free Customization in the Report Along with 30% Discount on the Study: https://www.infiniumglobalresearch.com/reports/request-discount/13252

"We Have Decided to Extend Our Support to the Industry on Account of Corona Outbreak by Offering Flat Discount 30% on All Our Studies and Evaluation of the Market Dynamics in Needle Free Drug Delivery Devices Amidst COVID-19."

Needle-Free Drug Delivery Devices Market Coverage

Chapter - 1           Preface

=> Report Description

=> Research Methods

=> Research Approaches

Chapter - 2           Executive Summary

=> Needle Free Drug Delivery Devices Market Highlights

=> Needle Free Drug Delivery Devices Market Projection

=> Needle Free Drug Delivery Devices Market Regional Highlights

Chapter - 3           Global Needle Free Drug Delivery Devices Market Overview

=> Introduction

=> Market Dynamics

=> Porter's Five Forces Analysis

=> IGR-Growth Matrix Analysis

=> Value Chain Analysis of Needle Free Drug Delivery Devices Market

Chapter - 4           Needle Free Drug Delivery Devices Market Macro Indicator Analysis

Chapter - 5           Global Needle Free Drug Delivery Devices Market by Technology

=> Jet Injectors

=> Inhaler Technology

=> Transdermal Patch Technology

=> Novel Needle-free Technologies

=> Oral Drug Delivery System

Chapter - 6           Global Needle Free Drug Delivery Devices Market by Application

=> Vaccine Delivery

=> Pain Management

=> Insulin Delivery for Diabetes

=> Pediatric Injections

=> Other Applications

Chapter - 7           Global Needle Free Drug Delivery Devices Market by Region 2019-2025

=> North America

=> Europe

=> Asia-Pacific

=> RoW

Chapter - 8           Company Profiles and Competitive Landscape

=> 3M

=> AkraDermojet Inc

=> Antares Pharma Inc.

=> Bayer AG

=> Bioject Medical Technologies, Inc.

=> GlaxoSmithKline plc

=> Glide Pharmaceutical Technologies Ltd.

=> InjexPharma AG

=> Medtronic, Inc.

=> Zogenix, Inc.

Chapter - 9           Appendix

=> Primary Research Findings and Questionnaire

Browse Complete Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-needle-free-drug-delivery-devices-market

About Infinium Global Research
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients.

To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations and environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.